Open AccessBNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age
Author(s) -
Chandra J. Cohen-Stavi,
Ori Magen,
Noam Barda,
Shlomit Yaron,
Alon Peretz,
Doron Netzer,
Carlo Giaquinto,
Ali Judd,
Leonard Leibovici,
Miguel A. Hernán,
Marc Lipsitch,
Ben Y. Reis,
Ran D. Balicer,
Noa Dagan
Publication year - 2022
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2205011
Subject(s) - covid-19 , medicine , disease , virology , infectious disease (medical specialty) , outbreak
Limited evidence is available on the real-world effectiveness of the BNT162b2 vaccine against coronavirus disease 2019 (Covid-19) and specifically against infection with the omicron variant among children 5 to 11 years of age.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom